UBI Pharma Inc. (UNQ: 6562)
Health Care · Biotechnology · TW
NT$—
— today · — 1Y
UBI Pharma Inc. (UNQ: 6562) operates in the Biotechnology industry within the Health Care sector. The company is valued at $52.10M.
trading between 10.00 and 42.54.
Tweenvest scores UBI Pharma Inc. across four factors: quality 53/100, value 39/100, growth 0/100. Its strongest factor is quality.
6562 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $52.10M
- Revenue (TTM)
- $14.68M
- P/E
- —
- EPS
- -2.24
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$42.54
- 52-week low
- NT$10.00
- Avg volume (3M)
- —
- Shares outstanding
- 118.19M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Helix BioPharma Corp.TSX: HBP | $52.51M | CA$0.92 | -6.12% |
| Prescient Therapeutics LimitedASX: PTX | $52.47M | AU$0.07 | -2.94% |
| ImageneBio, Inc.NasdaqCM: IMA | $52.22M | $4.26 | -7.39% |
| Edesa Biotech, Inc.NasdaqCM: EDSA | $52.15M | $3.66 | -5.18% |
| Sirnaomics Ltd.SEHK: 2257 | $51.97M | HK$3.75 | -1.45% |
| Kidswell Bio CorporationTSE: 4584 | $51.96M | ¥162.00 | -2.41% |
| Amicogen, Inc.KOSDAQ: A092040 | $51.69M | ₩988.00 | +5.67% |
| INmune Bio Inc.NasdaqCM: INMB | $51.62M | $1.83 | -1.61% |
Figures last refreshed Oct 4, 2026.